Our study found hypomethylation of the RHOF promoter in lymph node metastatic breast cancer tissue, which is likely to lead to elevated RHOF expression in positive lymph node tissue compared to negative lymph node tissue. The gene discussed is RHOF; the disease is breast carcinoma.